Tricuspid regurgitation screening

Jump to navigation Jump to search

Tricuspid Regurgitation Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Tricuspid Regurgitation from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Stages

History and Symptoms

Physical Examination

Laboratory Findings

Echocardiography

Chest X Ray

Electrocardiogram

Cardiac Stress Test

Cardiac MRI

Cardiac Catheterization

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Tricuspid regurgitation screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tricuspid regurgitation screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA onTricuspid regurgitation screening

CDC on Tricuspid regurgitation screening

Tricuspid regurgitation screening in the news

Blogs on Tricuspid regurgitation screening

Directions to Hospitals Treating Tricuspid regurgitation

Risk calculators and risk factors for Tricuspid regurgitation screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

There is insufficient evidence to recommend routine screening for tricuspid valve regurgitation. But there are some genetic conditions which might lead to tricuspid valve regurgitation and can be screened.

OR

According to the [guideline name], screening for [disease name] is not recommended.

OR

According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].

Screening

There is insufficient evidence to recommend routine screening for [disease/malignancy].

OR

According to the [guideline name], screening for [disease name] is not recommended.

OR

  • Genetic conditions like which might lead to tricuspid valve regurgitation include:[1][2]
    • Trisomy 21
    • Trisomy 18
    • Trisomy 13
    • Turner syndrome
  • Screening can be done by using the following in these patients, assessment of tricuspid blood flow along with the following:
    • Fetal nuchal translucency (NT) thickness
    • Fetal heart rate (FHR)
    • Serum free beta-human chorionic gonadotropin (beta-hCG)
    • Pregnancy-associated plasma protein A (PAPP-A)
  • [Condition 1]
  • [Condition 2]
  • [Condition 3]

References

  1. Kagan KO, Valencia C, Livanos P, Wright D, Nicolaides KH (2009). "Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11+0 to 13+6 weeks of gestation". Ultrasound Obstet Gynecol. 33 (1): 18–22. doi:10.1002/uog.6264. PMID 19031473.
  2. Falcon O, Auer M, Gerovassili A, Spencer K, Nicolaides KH (2006). "Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks". Ultrasound Obstet Gynecol. 27 (2): 151–5. doi:10.1002/uog.2699. PMID 16388509.

Template:WH Template:WS